According to a report on Forbes.com CSL Limited announced it is buying Talecris Therapeutics Holdings. CSL, once an Australian governmental body, has been sucking up the competition and complementary businesses for much of the 2000's. In 2000 CSL acquired ZLB Bioplasma AG, then scooped up Aventis Behring in 2004.Acquiring Talecris, formerly Bayer's plasma products division, CSL has bolstered its position in the plasma market.
Mergers and acquisitions are the nothing new in business and even for us in the bleeding disorders community. But this recent trend of consolidation for both the home health care providers and factor producers coupled with emerging trends in insurance coverage toward sole sourcing and limited choices really necessitates some attention and will require constant vigilance.
No comments:
Post a Comment